Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial

被引：0

作者：

Frantz, R. P. ^{[1
]}

McLaughlin, V. V. ^{[2
]}

Sahay, S. ^{[3
]}

Subias, P. Escribano ^{[4
]}

Zolty, R. L. ^{[5
]}

Benza, R. L. ^{[6
]}

Channick, R. N. ^{[7
]}

Chin, K. M. ^{[8
]}

Hemnes, A. R. ^{[9
]}

Howard, L. S. ^{[10
]}

Sitbon, O. ^{[11
]}

Vachiery, J. ^{[12
]}

Zamanian, R. T. ^{[13
]}

Cravets, M. ^{[14
]}

Roscigno, R. F. ^{[15
]}

Mottola, D. ^{[15
]}

Elman, E. ^{[16
]}

Parsley, E. ^{[15
]}

Aranda, R. ^{[17
]}

Zisman, L. S. ^{[15
]}

Ghofrani, H. ^{[18
]}

机构：

[1] Mayo Clin, Cardiovasc Med, Rochester, MN USA

[2] Univ Michigan, Cardiovasc Dis, Internal Med, Ann Arbor, MI USA

[3] Houston Methodist Hosp Weill Cornell Med, Div Pulm Crit Care & Sleep Med, Houston, TX USA

[4] Univ Complutense, Univ Hosp Octubre 12, Cardiol, Madrid, Spain

[5] Univ Nebraska Med Ctr, Internal Med, Omaha, NE USA

[6] Ohio State Univ, Wexner Med Ctr, Div Cardiovasc Dis, Columbus, OH USA

[7] UCLA Med Ctr, Pulmonol, Crit Care Med, Los Angeles, CA USA

[8] UT Southwestern Med Ctr, Internal Med, Dallas, TX USA

[9] Vanderbilt Univ, Dept Med, Nashville, TN USA

[10] Imperial Coll Healthcare NHS Trust, Cardiol, London, England

[11] Univ Paris Saclay, Hop Bicetre, Serv Pneumol, Le Kremlin Bicetre, France

[12] HUB Hop Erasme, Cardiol, Brussels, Belgium

[13] Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA USA

[14] Gossamer Bio Inc, Biometr, San Diego, CA USA

[15] Gossamer Bio Inc, Clin Dev, San Diego, CA USA

[16] Gossamer Bio Inc, Clin Operat, San Diego, CA USA

[17] Gossamer Bio Inc, Clin Execut, San Diego, CA USA

[18] Justus Liebig Univ Giessen, Dept Internal Med, Giessen, Germany

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6726

引用

页数：2

共 50 条

[1] Seralutinib improves pulmonary arterial blood vessel volume distribution in pulmonary arterial hypertension (PAH): results of the TORREY phase 2 imaging substudy
Zamanian, Roham
Rahaghi, Farbod N.
Howard, Luke S.
Delcroix, Marion
Sahay, Sandeep
Sood, Namita
Zolty, Ronald L.
Chakinala, Murali M.
Franco, Veronica
Jansa, Pavel
Shapiro, Shelley M.
Spikes, Leslie A.
Stevens, Wendy
White, R. James
Muchmore, Patrick
Lavon, Ben
De Backer, Jan
Duong-Verle, Thao
Roscigno, Robert F.
Mottola, David
Aranda, Richard
Cravets, Matt
Osterhout, Robin
Bruey, Jean-Marie
Parsley, Ed
Mclaughlin, Vallerie V.
Frantz, Robert P.
Ghofrani, Hossein-Ardeschir
Sitbon, Olivier
Zisman, Lawrence S.
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[2] TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
Frantz, Robert P.
Benza, Raymond L.
Channick, Richard N.
Chin, Kelly
Howard, Luke S.
McLaughlin, Vallerie V.
Sitbon, Olivier
Zamanian, Roham T.
Hemnes, Anna R.
Cravets, Matt
Bruey, Jean-Marie
Roscigno, Robert
Mottola, David
Elman, Erin
Zisman, Lawrence S.
Ghofrani, Hossein-Ardeschir
PULMONARY CIRCULATION, 2021, 11 (04)
[3] Evaluation of Seralutinib Treatment Effect Across Four Risk Tools in the TORREY Study in Pulmonary Arterial Hypertension (PAH)
Benza, R. L.
Osterhout, R.
Hoffman, S.
Zamanian, R. T.
Hemnes, A. R.
Channick, R. N.
Chin, K. M.
Frantz, R. P.
Ghofrani, A.
Howard, L. S.
McLaughlin, V. V.
Vachiery, J.
Zisman, L. S.
Cravets, M.
Bruey, J.
Roscigno, R. F.
Mottola, D.
Aranda, R.
Sitbon, O.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S86 - S87
[4] Cicletanine in pulmonary arterial hypertension (PAH): Results from a phase 2 randomized placebo-controlled trial
Waxman, Aaron
Oudiz, Ronald
Shapiro, Shelley
Gomberg-Maitland, Mardi
Keogh, Anne
Badesch, David
Frantz, Robert
Elliott, C. Gregory
Gillies, Hunter
Walker, Gennyne
EUROPEAN RESPIRATORY JOURNAL, 2012, 40
[5] Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
Pullamsetti, Soni Savai
Sitapara, Ravikumar
Osterhout, Robin
Weiss, Astrid
Carter, Laura L.
Zisman, Lawrence S.
Schermuly, Ralph Theo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
[6] Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
Barbera, Joan Albert
Galie, Nazzareno
Frost, Adaani
Ghofrani, Hossein Ardeschir
Hoeper, Marius
Mclaughlin, Vallerie
Peacock, Andrew
Simonneau, Gerald
Vachiery, Jean-Luc
Blair, Christiana
Miller, Karen
Harris, Julia
Langley, Jonathan
Rubin, Lewis
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[7] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
Kremers, Hilal Maradit
Slusser, Joshua P.
Scott, Christopher G.
Primatesta, Paola
McGoon, Michael D.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
[8] Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Hoeper, Marius M.
Badesch, David B.
Ghofrani, H. Ardeschir
Gibbs, J. Simon R.
Gomberg-Maitland, Mardi
McLaughlin, Vallerie V.
Preston, Ioana R.
Souza, Rogerio
Waxman, Aaron B.
Gruenig, Ekkehard
Kopec, Grzegorz
Meyer, Gisela
Olsson, Karen M.
Rosenkranz, Stephan
Xu, Yayun
Miller, Barry
Fowler, Marcie
Butler, John
Koglin, Joerg
Pena, Janethe de Oliveira
Humbert, Marc
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (16): : 1478 - 1490
[9] Effects of inhaled seralutinib on right ventricular-pulmonary arterial (RV-PA) coupling and right heart function in pulmonary arterial hypertension (PAH)
Frantz, R.
Tello, K.
Moles, V. M.
Solomon, S. D.
Cravets, M.
Osterhout, R.
Bruey, J. M.
Roscigno, R. F.
Aranda, R.
Vachiery, J. L.
Badagliacca, R.
Benza, R. L.
Mclaughlin, V. V.
Zisman, L. S.
Ghofrani, H. A.
EUROPEAN HEART JOURNAL, 2023, 44
[10] Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
Galkin, Anna
Sitapara, Ravikumar
Clemons, Bryan
Garcia, Eduardo
Kennedy, Michael
Guimond, David
Carter, Laura L.
Douthitt, Ashley
Osterhout, Robin
Gandjeva, Aneta
Slee, Deborah
Salter-Cid, Luisa
Tuder, Rubin M.
Zisman, Lawrence S.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (06)

← 1 2 3 4 5 →